Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Presentation TCT 2023

CTO PCI When Is It Indicated? Review of the Evidence

Presenter: Robert Yeh

October 26, 2023

Presentation TCT 2023

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

Agent DCB

Presenter: Robert Yeh

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

Overcoming the "Credibility Crisis" of Observational Data

Presenter: Robert Yeh

October 24, 2023

Presentation TCT 2023

Discussion and Closing Remarks

Presenter: Robert Yeh

October 24, 2023

Presentation TCT 2023

Opening Remarks and Learning Objectives

Presenter: Robert Yeh

October 24, 2023

News Daily News

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

L.A. McKeown

August 22, 2023

News Daily News

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Caitlin E. Cox

June 21, 2023

Presentation Fellows 2023

Defining the Role of Coronary IVL – New Data & Guidelines

Presenter: Robert Yeh

May 11, 2023

Presentation Fellows 2023

State-of-the-Art in NSTE-ACS: Management Strategies

Presenter: Robert Yeh

May 11, 2023

Video

» Conference Wrap-Up

TCT 2023 Day 2 Wrap-Up

October 24, 2023

Advertisement

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

CTO PCI When Is It Indicated? Review of the Evidence

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Agent DCB

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Overcoming the "Credibility Crisis" of Observational Data

Discussion and Closing Remarks

Opening Remarks and Learning Objectives

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Defining the Role of Coronary IVL – New Data & Guidelines

State-of-the-Art in NSTE-ACS: Management Strategies

TCT 2023 Day 2 Wrap-Up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content